These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25969132)

  • 1. Rare cancers in The Netherlands: a population-based study.
    van der Zwan JM; van Dijk BAC; Visser O; van Krieken HJHJM; Capocaccia R; Siesling S
    Eur J Cancer Prev; 2018 Jul; 27(4):384-390. PubMed ID: 25969132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study.
    Gatta G; Capocaccia R; Botta L; Mallone S; De Angelis R; Ardanaz E; Comber H; Dimitrova N; Leinonen MK; Siesling S; van der Zwan JM; Van Eycken L; Visser O; Žakelj MP; Anderson LA; Bella F; Kaire I; Otter R; Stiller CA; Trama A;
    Lancet Oncol; 2017 Aug; 18(8):1022-1039. PubMed ID: 28687376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The burden of rare cancer in Japan: application of the RARECARE definition.
    Tamaki T; Dong Y; Ohno Y; Sobue T; Nishimoto H; Shibata A
    Cancer Epidemiol; 2014 Oct; 38(5):490-5. PubMed ID: 25155209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.
    Mallone S; De Angelis R; van der Zwan JM; Trama A; Siesling S; Gatta G; Capocaccia R;
    Cancer Epidemiol; 2013 Dec; 37(6):850-6. PubMed ID: 24050903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare cancers of the head and neck area in Europe.
    Van Dijk BA; Gatta G; Capocaccia R; Pierannunzio D; Strojan P; Licitra L;
    Eur J Cancer; 2012 Apr; 48(6):783-96. PubMed ID: 22051735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare cancers are not so rare: the rare cancer burden in Europe.
    Gatta G; van der Zwan JM; Casali PG; Siesling S; Dei Tos AP; Kunkler I; Otter R; Licitra L; Mallone S; Tavilla A; Trama A; Capocaccia R;
    Eur J Cancer; 2011 Nov; 47(17):2493-511. PubMed ID: 22033323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU).
    Casali PG; Trama A
    ESMO Open; 2020 Mar; 5(2):. PubMed ID: 32220947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of rare cancers in the city of São Paulo, Brazil.
    Bustamante-Teixeira MT; Latorre MDRDO; Guerra MR; Tanaka LF; Botta L; Trama A; Gatta G
    Tumori; 2019 Feb; 105(1):22-30. PubMed ID: 30700226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of rare cancers and inequalities in oncologic outcomes.
    Gatta G; Trama A; Capocaccia R;
    Eur J Surg Oncol; 2019 Jan; 45(1):3-11. PubMed ID: 29032924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare cancers are not rare in Asia as well: The rare cancer burden in East Asia.
    Matsuda T; Won YJ; Chun-Ju Chiang R; Lim J; Saika K; Fukui K; Lee WC; Botta L; Bernasconi A; Trama A
    Cancer Epidemiol; 2020 Aug; 67():101702. PubMed ID: 32535408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data quality in rare cancers registration: the report of the RARECARE data quality study.
    Trama A; Marcos-Gragera R; Sánchez Pérez MJ; van der Zwan JM; Ardanaz E; Bouchardy C; Melchor JM; Martinez C; Capocaccia R; Vicentini M; Siesling S; Gatta G;
    Tumori; 2017 Jan; 103(1):22-32. PubMed ID: 27716878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoma of endocrine organs: results of the RARECARE project.
    van der Zwan JM; Mallone S; van Dijk B; Bielska-Lasota M; Otter R; Foschi R; Baudin E; Links TP;
    Eur J Cancer; 2012 Sep; 48(13):1923-31. PubMed ID: 22361014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.
    Ferrari A; Brecht IB; Gatta G; Schneider DT; Orbach D; Cecchetto G; Godzinski J; Reguerre Y; Bien E; Stachowicz-Stencel T; Ost M; Magni C; Kearns P; Vassal G; Massimino M; Biondi A; Bisogno G; Trama A
    Eur J Cancer; 2019 Mar; 110():120-126. PubMed ID: 30785015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare cancers in childhood and adolescence in Brazil: First report of data from 19 population-based cancer registries.
    Balmant NV; de Souza Reis R; de Oliveira Santos M; de Camargo B; Gatta G
    Cancer; 2019 Aug; 125(15):2638-2646. PubMed ID: 31013367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descriptive epidemiological study of rare, less common and common cancers in Western Australia.
    Bilkey GA; Trevithick RW; Coles EP; Girschik J; Nowak KJ
    BMC Cancer; 2021 Jul; 21(1):779. PubMed ID: 34233636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gap between rare and common cancers still exists: Results from a population-based study in the Netherlands.
    de Heus E; Duijts SFA; van der Zwan JM; Kapiteijn E; Nieveen van Dijkum EJM; van Herpen CML; Merkx MAW
    Eur J Cancer; 2022 May; 167():103-111. PubMed ID: 35421702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of rare cancers in Europe.
    Gatta G; Capocaccia R; Trama A; Martínez-García C;
    Adv Exp Med Biol; 2010; 686():285-303. PubMed ID: 20824452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare cancers in Canada, 2006-2016: A population-based surveillance report and comparison of different methods for classifying rare cancers.
    Walker EV; Maplethorpe E; Davis FG
    Cancer Epidemiol; 2020 Aug; 67():101721. PubMed ID: 32416499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project.
    Trama A; Mallone S; Ferretti S; Meduri F; Capocaccia R; Gatta G;
    Tumori; 2012; 98(5):550-8. PubMed ID: 23235748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.